Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$492M |
| 2 |
LLL
L3 Technologies, Inc.
LLL
|
+$392M |
| 3 |
Apple
AAPL
|
+$245M |
| 4 |
AGN
Allergan plc
AGN
|
+$238M |
| 5 |
NXP Semiconductors
NXPI
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$568M |
| 2 |
Coty
COTY
|
+$491M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$224M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$211M |
| 5 |
Sysco
SYY
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.43% |
| 2 | Healthcare | 13.06% |
| 3 | Technology | 11.97% |
| 4 | Financials | 10.69% |
| 5 | Consumer Discretionary | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRNB
2626
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $1.28M | ﹤0.01% |
38,716
+19,250
| +99% | +$601K |
|
2627
Madrigal Pharmaceuticals
MDGL
$12.6B
| $1.28M | ﹤0.01% |
12,231
+7,120
| +139% | +$763K |
|
2628
PUT
Insmed
INSM
$26.5B
| $1.28M | ﹤0.01% |
+50,000
| New | +$1.39M |
|
2629
Gorman-Rupp
GRC
$2.05B
| $1.28M | ﹤0.01% |
38,956
-16,428
| -30% | -$534K |
|
|
WCC
2630
WESCO International
WCC
$17.1B
| $1.28M | ﹤0.01% |
25,261
-159,324
| -86% | -$8.34M |
|
2631
Tetra Tech
TTEK
$9.38B
| $1.28M | ﹤0.01% |
81,285
-742,245
| -90% | -$10M |
|
|
PNNT
2632
Pennant Park Investment Corp
PNNT
$244M
| $1.27M | ﹤0.01% |
+201,046
| New | +$1.35M |
|
2633
Antero Midstream
AM
$10.7B
| $1.27M | ﹤0.01% |
110,815
-2,128,783
| -95% | -$27.3M |
|
2634
Iridium Communications
IRDM
$5.05B
| $1.27M | ﹤0.01% |
+54,614
| New | +$1.36M |
|
|
GBT
2635
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.27M | ﹤0.01% |
24,136
-115,406
| -83% | -$6.63M |
|
|
ALEX
2636
DELISTED
Alexander & Baldwin
ALEX
| $1.27M | ﹤0.01% |
54,952
+46,915
| +584% | +$1.11M |
|
2637
CALL
Globus Medical
GMED
$11.1B
| $1.27M | ﹤0.01% |
30,000
+10,000
| +50% | +$434K |
|
|
VER
2638
DELISTED
VEREIT, Inc.
VER
| $1.27M | ﹤0.01% |
+28,147
| New | +$1.22M |
|
2639
Natural Health Trends
NHTC
$14.7M
| $1.26M | ﹤0.01% |
157,035
+68,395
| +77% | +$715K |
|
2640
Tootsie Roll Industries
TR
$3.07B
| $1.26M | ﹤0.01% |
42,074
+4,285
| +11% | +$134K |
|
2641
Liberty Media Series C
FWONK
$25.6B
| $1.26M | ﹤0.01% |
+34,799
| New | +$1.26M |
|
2642
PUT
Honeywell
HON
$69.9B
| $1.26M | ﹤0.01% |
60,689
+212
| +0.4% | +$33.7K |
|
2643
AC Immune
ACIU
$269M
| $1.25M | ﹤0.01% |
225,974
+56,215
| +33% | +$286K |
|
2644
CALL
MPLX
MPLX
$60.3B
| $1.25M | ﹤0.01% |
+38,900
| New | +$1.24M |
|
2645
Simulations Plus
SLP
$373M
| $1.25M | ﹤0.01% |
+43,645
| New | +$1.06M |
|
|
AEL
2646
DELISTED
American Equity Investment Life Holding Company
AEL
| $1.24M | ﹤0.01% |
45,806
-58,258
| -56% | -$1.67M |
|
|
ORBC
2647
DELISTED
ORBCOMM, Inc.
ORBC
| $1.24M | ﹤0.01% |
171,608
-45,297
| -21% | -$322K |
|
2648
Kulicke & Soffa
KLIC
$4.43B
| $1.24M | ﹤0.01% |
55,064
+37,064
| +206% | +$814K |
|
2649
Scholastic
SCHL
$738M
| $1.24M | ﹤0.01% |
37,364
-8,280
| -18% | -$309K |
|
|
SCHW
2650
PUT
Charles Schwab
SCHW
$187B
| $1.24M | ﹤0.01% |
+30,800
| New | +$1.34M |
|
Similar funds
Israel Englander's Q2 2019 Portfolio in Review
As of Q2 2019, Israel Englander held 4,801 positions worth $66.5B, down 0.45% from $66.8B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.
Israel Englander withdrew a net $3.96B in Q2 2019, closing 810 positions and reducing 1,571 holdings. Its most notable exit was Sysco, an estimated $208M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Israel Englander opened a new position in Moody's worth $125M.
- Israel Englander's largest Q2 2019 buy was Moody's: 638,271 shares worth $125M.
- Israel Englander added most to LyondellBasell Industries in Q2 2019, an estimated $492M increase.
- Israel Englander's biggest Q2 2019 reduction was Walt Disney, cutting an estimated $568M.
- Israel Englander fully exited Sysco in Q2 2019, selling an estimated $208M.
- Israel Englander's ten largest holdings make up 7.7% of its $66.5B portfolio in Q2 2019.
- Israel Englander opened 865 new positions and closed 810 in Q2 2019.
- Israel Englander's portfolio value fell 0.45% quarter-over-quarter to $66.5B.
Based on Millennium Management's 13F filing for Q2 2019, filed 14 Aug 2019.